BridgeBio Oncology Therapeutics Inc (BBOT)

BridgeBio Oncology Therapeutics witnessed a single proposed sale of 78 shares valued at 183.3 USD by officer Marc Cobo on November 13, 2026. This activity follows a recent earnings report showing a 33.8% EPS beat. The stock has experienced a 76.3% decline over the past ninety days, trading significantly below its annual peak.
Ticker: BBOT Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cobo Marc Principal Accounting Officer Officer
Transaction date
Planned sale
Price
430.99
Quantity 64,163 -33.2%
Value US$666,100
MARC COBO Officer Officer
Transaction date
Proposed sale
Price
12.76
Quantity 52,827
Value US$4,021,798
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
279.69
Quantity 78,056 -2.7%
Value US$4,191,097
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 1,427,040 New position
Value US$14,270,400
2.2
Chen Bihua CEO and Chairperson Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 69,360 New position
Value US$693,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-17 2026-11-13 PlS Planned sale

Principal Accounting Officer

Officer
64,163 -33.2%
430.99
US$666,100
64,163 -33.2% 430.99 US$666,100
2026-11-13 2026-11-13 PrS Proposed sale

Officer

Officer
52,827
12.76
US$4,021,798
52,827 12.76 US$4,021,798
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
78,056 -2.7%
279.69
US$4,191,097
78,056 -2.7% 279.69 US$4,191,097
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
1,427,040 New position
10.00
US$14,270,400
1,427,040 New position 10.00 US$14,270,400
2024-02-13 2024-02-13 B Purchase

CEO and Chairperson

Executive Director Large shareholder
69,360 New position
10.00
US$693,600
69,360 New position 10.00 US$693,600